• EP 145: Navigating rare disease drug development regulations with Daniel O’Connor

  • Aug 1 2024
  • Duración: 39 m
  • Podcast

EP 145: Navigating rare disease drug development regulations with Daniel O’Connor

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, we’re joined by Daniel O’Connor, Director of Regulatory Policy and Early Access at The Association of the British Pharmaceutical Industry. Daniel previously spent almost 18 years at the Medicines and Healthcare products Regulatory Agency (MHRA) and over his career has specialized in improving and incentivizing pathways to rare disease treatment development. Join Patrick and Daniel as they discuss orphan drug designation, the importance of international collaboration, and how unlocking new regulatory approaches to preventative medicine can help change the future of rare and ultra-rare conditions.
    Más Menos
Ciencias Biológicas Historia Natural
Más Menos

Lo que los oyentes dicen sobre EP 145: Navigating rare disease drug development regulations with Daniel O’Connor

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles